In addition, the general increase of PC and SM concentration in cerebrospinal fluid (CSF) was found positively associated with amyloid positivity and tau levels among cognitive impairment patients, and at the same time associated with progression from mild cognitive impairment to dementia in long-term follow-up [11,12]. The gene discussed is MAPT; the disease is Cognitive impairment.